National Philanthropic Trust’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.8M Hold
492,112
0.26% 44
2026
Q1
$12.1M Hold
492,112
0.13% 55
2025
Q4
$8.32M Hold
492,112
0.08% 70
2025
Q3
$10.7M Hold
492,112
0.12% 52
2025
Q2
$7.01M Hold
492,112
0.09% 71
2025
Q1
$6.39M Hold
492,112
0.1% 70
2024
Q4
$6.55M Hold
492,112
0.09% 76
2024
Q3
$2.95M Hold
492,112
0.05% 100
2024
Q2
$1.62M Hold
492,112
0.03% 123
2024
Q1
$1.85M Hold
492,112
0.04% 118
2023
Q4
$2.16M Buy
+492,112
New +$1.97M 0.06% 110

Other funds holding ETON

National Philanthropic Trust's ETON Position: Q2 2026 in Review

National Philanthropic Trust held its Eton Pharmaceutcials (ETON) position steady in Q2 2026 at 492,112 shares worth $17.8M. The position accounts for 0.26% of the portfolio, ranked #44.

National Philanthropic Trust first reported a position in ETON in Q4 2023 and has held it in 11 quarters since. 149 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • National Philanthropic Trust held 492,112 shares of Eton Pharmaceutcials worth $17.8M as of Q2 2026.
  • National Philanthropic Trust left its Eton Pharmaceutcials share count unchanged in Q2 2026.
  • Eton Pharmaceutcials made up 0.26% of National Philanthropic Trust's portfolio in Q2 2026, its #44 holding.
  • National Philanthropic Trust first reported a position in Eton Pharmaceutcials in Q4 2023 and has held it in 11 quarters since.
  • 149 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on National Philanthropic Trust's 13F filing for Q2 2026, filed 14 Aug 2026.